Epidemiology and prognostic factors of candidemia in cancer patients.
about
Central venous catheter (CVC) removal for patients of all ages with candidaemiaComponents of the calcium-calcineurin signaling pathway in fungal cells and their potential as antifungal targetsIn Vitro and In Vivo Antifungal Activity of Lichochalcone-A against Candida albicans BiofilmsClinical and therapeutic aspects of candidemia: a five year single centre study.Quick Detection of FKS1 Mutations Responsible for Clinical Echinocandin Resistance in Candida albicans.Fibronectin-, vitronectin- and laminin-binding proteins at the cell walls of Candida parapsilosis and Candida tropicalis pathogenic yeasts.Activity of Novel Synthetic Peptides against Candida albicans.Inhibitory activity of hinokitiol against biofilm formation in fluconazole-resistant Candida species.Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.The risk and clinical outcome of candidemia depending on underlying malignancy.Drug resistance mechanisms and their regulation in non-albicans Candida species.Admission to the Intensive Care Unit is Associated With Changes in the Oral Mycobiome.Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA.Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients.Lactoferrin, chitosan and Melaleuca alternifolia-natural products that show promise in candidiasis treatment.Epidemiological Study on Candida Species in Patients with Cancer in the Intensive Care Unit.Central venous access in oncology: ESMO Clinical Practice Guidelines.The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans.
P2860
Q26471135-8B5F8A66-E095-418D-A10F-9BEA4305F764Q28080558-D2294A04-8A0A-4889-AA27-18872B034E45Q28550206-682E4EE8-6C61-4916-802C-7BF6F971A7C3Q35641217-FDC245C8-0715-4F8D-ACA3-C33E6D2CE431Q35757564-14CAAF82-C318-4EB7-8D16-7CAE7792F595Q35799819-B4476BD7-B8E6-472F-B464-47B277170358Q36154522-0EA4C026-3DA6-4E4A-AC93-EA1209F7CA85Q36267962-921B3D8F-4BCD-4F9C-A508-886C9C74C7F4Q37580801-5D9693C8-0312-41A7-8324-13FF4BCDDB93Q37742252-9A6474F5-79B8-48BA-B141-3D0CE8F3010BQ38708362-4B0D6FDD-2C4C-44FA-8C9C-EF085F1BB22FQ40785545-4F9071DD-84C9-44CA-BF6B-84ACC7F8A8CEQ40942390-48BE20C2-E564-4A7B-8DA6-3623BDB83A07Q41987503-C772AC5E-DEC6-41ED-AA0A-FFD8621DDCF9Q46262525-FDFB8E9A-7FEC-45F5-8A8A-BFC6EE1DD53EQ49891134-85CA5AF9-3EAA-4F93-AC50-71681EF0F413Q51792973-EEB90FB8-0277-4509-91D5-AC523F86D01CQ53561135-0306BEF1-0C6C-4C99-A7B5-B27553EA2BC9
P2860
Epidemiology and prognostic factors of candidemia in cancer patients.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Epidemiology and prognostic factors of candidemia in cancer patients.
@ast
Epidemiology and prognostic factors of candidemia in cancer patients.
@en
type
label
Epidemiology and prognostic factors of candidemia in cancer patients.
@ast
Epidemiology and prognostic factors of candidemia in cancer patients.
@en
prefLabel
Epidemiology and prognostic factors of candidemia in cancer patients.
@ast
Epidemiology and prognostic factors of candidemia in cancer patients.
@en
P2093
P2860
P1433
P1476
Epidemiology and prognostic factors of candidemia in cancer patients.
@en
P2093
Chih-Cheng Lai
Hsin-Lan Lin
Hung-Jen Tang
Wei-Lun Liu
P2860
P304
P356
10.1371/JOURNAL.PONE.0099103
P407
P577
2014-06-05T00:00:00Z